Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.

Martin Plymoth Robert LundquistAnders NystedtAnders Sjöstedt Tomas N Gustafsson

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

We comprehensively summarize clinical, laboratory, and treatment outcomes of type B tularemia. Targeting tularemia requires clinical awareness, early diagnosis, and timely commencement of treatment for an appropriate duration.

Keyphrases

cancer therapy
cross sectional
drug delivery
combination therapy
replacement therapy